Humana Inc (NYSE: HUM) flaunted slowness of -6.01% at $264.94, as the Stock market unbolted on Wednesday, before settling in for the price of $281.87 at the close. Taking a more long-term approach, HUM posted a 52-week range of $206.87-$315.35.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -13.05%. Meanwhile, its Annual Earning per share during the time was -13.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.43%. This publicly-traded company’s shares outstanding now amounts to $120.27 million, simultaneously with a float of $119.99 million. The organization now has a market capitalization sitting at $31.86 billion. At the time of writing, stock’s 50-day Moving Average stood at $279.86, while the 200-day Moving Average is $262.71.
Humana Inc (HUM) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Humana Inc industry. Humana Inc’s current insider ownership accounts for 0.23%, in contrast to 101.09% institutional ownership. According to the most recent insider trade that took place on May 14 ’25, this organization’s President & CEO bought 6,530 shares at the rate of 229.25, making the entire transaction reach 1,496,984 in total value, affecting insider ownership by 30,474.
Humana Inc (HUM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.52 per share during the current fiscal year.
Humana Inc’s EPS increase for this current 12-month fiscal period is 5.43% and is forecasted to reach 13.37 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.59% through the next 5 years, which can be compared against the -13.05% growth it accomplished over the previous five years trading on the market.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Let’s observe the current performance indicators for Humana Inc (HUM). Alongside those numbers, its PE Ratio stands at $20.33, and its Beta score is 0.45. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.26. Similarly, its price to free cash flow for trailing twelve months is now 13.06.
In the same vein, HUM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 13.03, a figure that is expected to reach -3.80 in the next quarter, and analysts are predicting that it will be 13.37 at the market close of one year from today.
Technical Analysis of Humana Inc (HUM)
Now, what If we examine the latest scores posted by [Humana Inc, HUM]. During the last 5-days, its volume was better the volume of 1.77 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 31.83% While, its Average True Range was 33.51.
Raw Stochastic average of Humana Inc (HUM) in the period of the previous 100 days is set at 53.53%, which indicates a major rise in contrast to 28.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 9.41 that was higher than 9.11 volatility it exhibited in the past 100-days period.
